New hope for advanced breast cancer patients

Since October is designated as Breast Cancer Awareness month, I thought that before it runs out, I should share a heartening report I have just read in the November 2012 edition of Life Extension magazine. It is all about the latest human clinical trial being conducted by a team of physicians and scientists, using a sophisticated form of laser/treatment therapy to treat advanced breast cancer in women.

The technique being used, known as laser-assisted immunotherapy, is described as the first of its kind. It has the ability to destroy both an advanced primary tumour and life-threatening metastases. It involves no surgery, chemotherapy or radiotherapy. It has the potential to act as a cancer vaccine, effectively preventing the same cancer from recurring.

Of particular significance is the lack of serious side effects caused by the said technique.

According to the report: “The results of the first human study are encouraging. Among all 15 subjects in the study, 80 per cent remain alive today. Compare that with the typical survival rate in the US for women with such advanced breast cancer, which is only 23.8 per cent at five years.”

For more information regarding the availability of the laser-assisted immunotherapy for breast cancer, one should call International Cancer Alliance.